Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 879512, 9 pages
http://dx.doi.org/10.1155/2013/879512
Research Article

Xiao-Ai-Ping, a TCM Injection, Enhances the Antigrowth Effects of Cisplatin on Lewis Lung Cancer Cells through Promoting the Infiltration and Function of CD8+ T Lymphocytes

1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 22 Hankou Road, Nanjing 210093, China
2Department of Clinical Oncology, The First Affiliated Hospital of Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, China

Received 27 March 2013; Revised 17 June 2013; Accepted 28 June 2013

Academic Editor: Kevin Chen

Copyright © 2013 Wanshuai Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Foulds, J. Radons, M. Kreuzer, G. Multhoff, and A. G. Pockley, “Influence of tumors on protective anti-tumor immunity and the effects of irradiation,” Frontiers in Oncology, vol. 3, article 14, 2013. View at Google Scholar
  2. G. Chen and L. A. Emens, “Chemoimmunotherapy: reengineering tumor immunity,” Cancer Immunology, Immunotherapy, vol. 62, no. 2, pp. 203–216, 2013. View at Publisher · View at Google Scholar
  3. I. Mellman, G. Coukos, and G. Dranoff, “Cancer immunotherapy comes of age,” Nature, vol. 480, no. 7378, pp. 480–489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. L. Topalian, F. S. Hodi, J. R. Brahmer et al., “Safety, activity, and immune correlates of anti-PD-1 antibody in cancer,” The New England Journal of Medicine, vol. 366, no. 26, pp. 2443–2454, 2012. View at Publisher · View at Google Scholar
  5. J. R. Brahmer, S. S. Tykodi, L. Q. Chow et al., “Safety and activity of anti-PD-L1 antibody in patients with advanced cancer,” The New England Journal of Medicine, vol. 366, no. 26, pp. 2455–2465, 2012. View at Publisher · View at Google Scholar
  6. A. Mallick, S. Barik, K. K. Goswami et al., “Neem leaf glycoprotein activates CD8+ T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma,” PLoS ONE, vol. 8, no. 1, Article ID e47434, 2013. View at Publisher · View at Google Scholar
  7. E. M. Higham, C. Shen, K. D. Wittrup, and J. Chen, “Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model,” Journal of Immunology, vol. 184, no. 11, pp. 5954–5958, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Wu, M. A. Forget, J. Chacon et al., “Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook,” Cancer Journal, vol. 18, no. 2, pp. 160–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. I. Sin, J. B. Park, I. H. Lee et al., “Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2180-188-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2180-188 peptides,” Cancer Immunology, Immunotherapy, vol. 61, no. 10, pp. 1671–1682, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. W. F. Cheng, C. F. Hung, K. Y. Lin et al., “CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination,” Gene Therapy, vol. 10, no. 16, pp. 1311–1320, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. Hollenbaugh and R. W. Dutton, “IFN-γ or CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor,” Journal of Immunology, vol. 177, no. 5, pp. 3004–3011, 2006. View at Google Scholar · View at Scopus
  12. Z. Huang, H. Lin, Y. Wang, Z. Cao, W. Lin, and Q. Chen, “Studies on the anti-angiogenic effect of Marsdenia tenacissima extract in vitro and in vivo,” Oncology Letters, vol. 5, no. 3, pp. 917–922, 2013. View at Google Scholar
  13. E. M. Saleh, R. A. El-Awady, and N. Anis, “Predictive markers for the response to 5-fluorouracil therapy in cancer cells: constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based chemotherapy,” Oncology Letters, vol. 5, no. 1, pp. 321–327, 2013. View at Google Scholar
  14. T. Watanabe, “Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer,” Breast Cancer, 2013. View at Publisher · View at Google Scholar
  15. T. H. Kang, C. P. Mao, S. Y. Lee et al., “Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity,” Cancer Research, vol. 73, no. 8, pp. 2493–2504, 2013. View at Publisher · View at Google Scholar
  16. G. Murugaiyan and B. Saha, “IL-27 in tumor immunity and immunotherapy,” Trends in Molecular Medicine, vol. 19, no. 2, pp. 108–116, 2013. View at Publisher · View at Google Scholar
  17. C. Pasero and D. Olive, “Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity,” Immunology Letters, vol. 151, no. 1-2, pp. 71–75, 2013. View at Publisher · View at Google Scholar
  18. R. G. Mehta, G. Murillo, R. Naithani, and X. Peng, “Cancer chemoprevention by natural products: how far have we come?” Pharmaceutical Research, vol. 27, no. 6, pp. 950–961, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. H. F. Ji, X. J. Li, and H. Y. Zhang, “Natural products and drug discovery: can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?” EMBO Reports, vol. 10, no. 3, pp. 194–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. I. Gray, J. O. Igoli, and R. Edrada-Ebel, “Natural products isolation in modern drug discovery programs,” Methods in Molecular Biology, vol. 864, pp. 515–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Mondal, S. Bandyopadhyay, M. K. Ghosh, S. Mukhopadhyay, S. Roy, and C. Mandal, “Natural products: promising resources for cancer drug discovery,” Anti-Cancer Agents in Medicinal Chemistry, vol. 12, no. 1, pp. 49–75, 2012. View at Google Scholar · View at Scopus
  22. Y. Tu and B. Yan, “High-throughput fractionation of natural products for drug discovery,” Methods in Molecular Biology, vol. 918, pp. 117–126, 2012. View at Publisher · View at Google Scholar
  23. N. I. Vasilevich, R. V. Kombarov, D. V. Genis, and M. A. Kirpichenok, “Lessons from natural products chemistry can offer novel approaches for synthetic chemistry in drug discovery,” Journal of Medicinal Chemistry, vol. 55, no. 16, pp. 7003–7009, 2012. View at Publisher · View at Google Scholar
  24. H. Zhang, A. M. Tan, A. Y. Zhang, R. Chen, S. Yang, and X. Huang, “Five new C21 steroidal glycosides from the stems of Marsdenia tenacissima,” Steroids, vol. 75, no. 2, pp. 176–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. X. Qiu, S. Q. Luo, L. Z. Lin, and G. A. Cordell, “Further polyoxypregnanes from Marsdenia tenacissima,” Phytochemistry, vol. 41, no. 5, pp. 1385–1388, 1996. View at Google Scholar · View at Scopus
  26. W. Y. Wang, Y. Zhou, X. J. Zhang, T. H. Gao, Z. F. Luo, and M. Y. Liu, “A random study of xiaoaiping injection combined with chemotherapy on the treatment of advanced non-small cell lung cancer,” Chinese Clinical Oncology, vol. 14, pp. 936–938, 2009 (Chinese). View at Google Scholar
  27. Z. Q. Huang, H. Tan, C. Y. Wang et al., “Clinical research of combined xiaoaiping injection with chemotherapy on advanced non-small cell lung cancer,” Chinese Clinical Oncology, vol. 12, pp. 97–99, 2007 (Chinese). View at Google Scholar
  28. W. Ken and G. Zhixiong, “Xiaoaiping injection combining with NP regiment in the treatment of 56 patients with advanced lung cancer,” Journal of Basic and Clinical Oncology, vol. 22, pp. 47–48, 2009 (Chinese). View at Google Scholar
  29. W. Li, R. Song, X. Fang et al., “SBF-1, a synthetic steroidal glycoside, inhibits melanoma growth and metastasis through blocking interaction between PDK1 and AKT3,” Biochemical Pharmacology, vol. 84, no. 2, pp. 172–181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. V. Novitskiy, I. Csiki, Y. Huang et al., “Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cells,” Journal of Thoracic Oncology, vol. 5, no. 9, pp. 1410–1415, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Song, C. Xiong, W. Lu, G. Ku, G. Huang, and C. Li, “Apoptosis imaging probe predicts early chemotherapy response in preclinical models: a comparative study with 18F-FDG PET,” Journal of Nuclear Medicine, vol. 54, no. 1, pp. 104–110, 2013. View at Publisher · View at Google Scholar
  32. J. S. Kang, H. G. Kang, Y. I. Park et al., “Expression of epithelial cell adhesion molecule and proliferating cell nuclear antigen in diethylnitrosamine-induced hepatocarcinogenesis in mice,” Experimental and Therapeutic Medicine, vol. 5, no. 1, pp. 138–142, 2013. View at Publisher · View at Google Scholar
  33. Y. Lazrek, O. Dubreuil, V. Garambois et al., “Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation,” Neoplasia, vol. 15, no. 3, pp. 335–347, 2013. View at Google Scholar
  34. A. Gopalan, W. Yu, B. G. Sanders, and K. Kline, “Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway,” Cancer Letters, vol. 329, no. 1, pp. 9–16, 2013. View at Publisher · View at Google Scholar
  35. C. B. Ryder, K. McColl, and C. W. Distelhorst, “Acidosis blocks CCAAT/enhancer-binding protein homologous protein (CHOP)- and c-Jun-mediated induction of p53-upregulated mediator of apoptosis (PUMA) during amino acid starvation,” Biochemical and Biophysical Research Communications, vol. 430, no. 4, pp. 1283–1288, 2013. View at Publisher · View at Google Scholar
  36. A. Boissonnas, F. Licata, L. Poupel et al., “CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network,” Neoplasia, vol. 15, no. 1, pp. 85–94, 2013. View at Google Scholar
  37. M. Kremer, Y. Suezer, A. Volz et al., “Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox,” PLoS Pathogens, vol. 8, no. 3, Article ID e1002557, 2012. View at Publisher · View at Google Scholar
  38. J. C. Silverio, I. R. Pereira, C. C. Mda et al., “CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy,” PLoS Pathogens, vol. 8, no. 4, Article ID e1002645, 2012. View at Publisher · View at Google Scholar